In conclusion, this study suggests that COMMD3 may act as a novel regulator of MM proliferation and metastasis, with its potential tumor-promoting effects associated with the COMMD3/ATOX1-ATP7A-LOX axis and copper metabolism pathways. This evidence concerns the gene LOX and Miyoshi myopathy.